Analysed BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) News Sources
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
20-02-2026
yahoo.com
Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February
26-02-2026
yahoo.com
BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
19-05-2026
yahoo.com
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
28-07-2026
yahoo.com
BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update
31-03-2026
yahoo.com
BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
15-05-2026
yahoo.com
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
28-05-2026
yahoo.com
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
02-06-2026
yahoo.com
BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
14-08-2026
yahoo.com
What is the current price of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)?
The current price of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) is $1.1675.
BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) since the previous trading day is $0.1025.
BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) since the previous trading day is 9.6244%.
What is the most recent average sentiment score for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)?
The most recent average sentiment score for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) is 84 out of 100.
What is the most recent average sentiment for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)?
The most recent sentiment for BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS) is .
SEC-8K** Filing Available For BRAINSTORM CELL THERAPEUTICS (BCLI:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.